The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the ...

The FDA has approved AstraZeneca's FluMist nasal spray to be used outside of a health care setting. Outside a Trump rally in ...

The vaccine, called FluMist, is a nasal vaccine that's been available since 2003 but given in-clinic by a healthcare provider ...

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...

FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...